iShares NASDAQ Biotechnology Index (IBB) Downgraded by Vetr Inc. to “Hold” – The Cerbat Gem

Posted: Published on June 5th, 2017

This post was added by Dr P. Richardson


Investorplace.com
iShares NASDAQ Biotechnology Index (IBB) Downgraded by Vetr Inc. to "Hold"
The Cerbat Gem
iShares NASDAQ Biotechnology Index logo iShares NASDAQ Biotechnology Index (NASDAQ:IBB) was downgraded by equities research analysts at Vetr from a buy rating to a hold rating in a report issued on Monday. They presently have a $307.00 target ...
Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB)Investorplace.com
iShares NASDAQ Biotechnology Index (IBB) Given News Impact Score of 0.10Sports Perspectives
First Personal Financial Services Lowers Position in iShares NASDAQ Biotechnology Index (IBB)BBNS
Chaffey Breeze -Stock Observer -BNB Daily (blog)
all 73 news articles »

See original here:
iShares NASDAQ Biotechnology Index (IBB) Downgraded by Vetr Inc. to "Hold" - The Cerbat Gem

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.